Our current study is not only in complete agreement with the findings showing that blocking IL-1 signaling effectively attenuates ozone-induced airway inflammation, but further provides a mechanistic link demonstrating that IL-17A-producing γδT-cells bridge IL-1 signaling and airway inflammation. The gene discussed is IL17A; the disease is inflammatory response.